Wird geladen...
A236 METRONIDAZOLE IN THE TREATMENT OF RECURRENT HEPATIC ENCEPHALOPATHY: A CASE SERIES.
BACKGROUND: Hepatic encephalopathy (HE) affects 50–70% of cirrhotic patients. Lactulose is first-line therapy in HE prevention and in preventing recurrent HE. Rifaximin (RIF) is the next therapeutic choice for HE prevention after two recurrent HE episodes despite lactulose treatment. RIF has been su...
Gespeichert in:
| Veröffentlicht in: | J Can Assoc Gastroenterol |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507794/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.237 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|